Skip to content
Open access

Neurobehavioral and Gene Expression Modulation by LTheanine in a Chronic Unpredictable Mild Stress Model in Wistar Albino Rats

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations

Abstract

Background: Chronic stress contributes significantly to anxiety and depression through dysregulation of the hypothalamic– pituitary–adrenal (HPA) axis and associated molecular pathways. L-theanine, a natural amino acid, exhibits potential neuroprotective and anxiolytic effects. Objective: To evaluate the effects of L-theanine on behavioral and gene expression alterations in an Unpredictable Chronic Mild Stress (UCMS)-induced Wistar albino rat model. Methods: Wistar albino rats were subjected to UCMS to induce chronic stress. Behavioral assessments were performed using the Elevated Plus Maze (EPM) and actophotometer to evaluate anxiety-like behavior and locomotor activity, respectively. Gene expression analysis was conducted using RT-PCR for key stress-related genes including BDNF, GABRA1, CRHR2, FADD, CDK6, and NR3C1. Results: UCMS significantly induced anxiety-like behavior, evidenced by reduced time spent in open arms and increased time in closed arms in the EPM, along with decreased locomotor activity. L-theanine treatment significantly improved these behavioral parameters compared to the stress group and showed comparable or superior effects to fluoxetine. At the molecular level, UCMS caused downregulation of BDNF, CRHR2, CDK6, and NR3C1, and upregulation of GABRA1 and FADD. L-theanine treatment effectively restored these gene expression changes toward normal levels. Conclusion: L-theanine exhibits significant anxiolytic and antidepressant-like effects by improving behavioral outcomes and modulating stress-induced gene expression. These findings highlight its therapeutic potential in managing stressrelated neuropsychiatric disorders.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.